Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 Complex
- 20 October 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 11 (1) , 93-108
Abstract
The engagement of the T-cell receptor (TCR) by a specific peptide–MHC ligand initiates transmembrane signaling to induce T-cell activation, a key step in most adaptive immune responses. Previous studies have indicated that TCR signaling is tightly regulated by cholesterol and its sulfate metabolite, cholesterol sulfate (CS), on the membrane. Here, we report a novel mechanism by which CS modulates TCR signaling through a conformational change of CD3 subunits. We found that the negatively charged CS interacted with the positively charged cytoplasmic domain of CD3ε (CD3εCD) to enhance its binding to the cell membrane and induce a stable secondary structure. This secondary structure suppressed the release of CD3εCD from the membrane in the presence of Ca2+, which in turn inhibited TCR phosphorylation and signaling. When a point mutation (I/A) was introduced to the intracellular immunoreceptor tyrosine-based activation motifs (YxxI-x6–8-YxxL) of CD3ε subunit, it reduced the stability of the secondary structure and regained sensitivity to Ca2+, which abolished CS-mediated inhibition and enhanced the signaling of the TCR complex. Notably, the I/A mutation could be applied to both murine and human TCR-T cell therapy to improve the antitumor efficacy. Our study reveals insights into the regulatory mechanism of TCR signaling and provides a strategy to functionally engineer the TCR/CD3 complex for T cell–based cancer immunotherapy.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82230055)
- National Natural Science Foundation of China (82071852)
This publication has 43 references indexed in Scilit:
- Local changes in lipid environment of TCR microclusters regulate membrane binding by the CD3ε cytoplasmic domainJournal of Experimental Medicine, 2012
- TCR Signaling Emerges from the Sum of Many PartsFrontiers in Immunology, 2012
- Basic residues in the T-cell receptor ζ cytoplasmic domain mediate membrane association and modulate signalingProceedings of the National Academy of Sciences, 2011
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patientsJournal of Clinical Investigation, 2011
- Complete but curtailed T-cell response to very low-affinity antigenNature, 2009
- Regulation of T Cell Receptor Activation by Dynamic Membrane Binding of the CD3ɛ Cytoplasmic Tyrosine-Based MotifCell, 2008
- Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversityMolecular Immunology, 2008
- T cell activation enhancement by endogenous pMHC acts for both weak and strong agonists but varies with differentiation stateJournal of Experimental Medicine, 2007
- Lipid-Binding Activity of Intrinsically Unstructured Cytoplasmic Domains of Multichain Immune Recognition Receptor Signaling SubunitsBiochemistry, 2006
- LIGAND RECOGNITION BY αβ T CELL RECEPTORSAnnual Review of Immunology, 1998